Monopar Therapeutics Inc (NASDAQ:MNPR)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MNPR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MNPR

  • Market Cap$52.610m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS61023L1089

Company Profile

Monopar Therapeutics Inc is the United States-based clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients. Its pipeline products comprise of Validive, Camsirubicin, and MNPR-101.

Latest MNPR news

Currently there for this company. Visit our news hub for other news .